DINO Drops 9% on Earnings Day as Piper Sandler Steps In

HF Sinclair reported third-quarter results Tuesday and the stock fell hard, closing at $114.21, a drop of nearly 9% on the day and 8.9% for the week, even as the broader refining complex sold off in tandem.

The sector move was real but DINO held up slightly better than its weakest peers. VLO fell 10.6% on the week. PBF dropped 11.3%. PARR was off 12.4%. MPC and PSX each lost around 8%. Against that backdrop, DINO's decline lands roughly in the middle of the peer distribution, a relative outcome that mirrors the pattern from the previous earnings print in August, when the stock fell 1.9% on the day before recovering 10.7% over the following five days.

The most notable data point heading into the session was a fresh analyst assumption. Piper Sandler assumed coverage Tuesday morning with an Overweight rating and a $152 target, the highest on the Street by a clear margin. That came alongside a broader backdrop of target raises over the past few weeks: Goldman Sachs at $142, Raymond James at $140, Wells Fargo at $135, UBS at $133, and Morgan Stanley at $127. The consensus target now runs around $124, roughly 8.5% above the current price. The split in the ratings, however, remains genuine. TD Cowen kept its Hold with a $110 target. Barclays and Wells Fargo carry Equal-Weight designations. Evercore ISI is In-Line. Several of the bullish target raises came paired with neutral ratings, meaning the Street is lifting its valuation range without uniformly endorsing the stock. The week's share price move has now dragged DINO below TD Cowen's target and within touching distance of Barclays' $122.

Positioning in the lending market offers little drama. Short interest has been declining for most of October, falling from around 10 million shares in early October to just under 7 million now, a drop of roughly 31% over the past month. At 3.8% of free float, the short base is modest. Borrow availability is extraordinarily wide, with over 155 million shares available against fewer than 7 million borrowed, and the cost to borrow has halved over the past week to 0.24%. There is no squeeze dynamic here, no scarcity in the lending pool, and no evidence of short sellers piling in ahead of results. Options positioning is equally unremarkable: the put/call ratio of 0.58 is barely above its 20-day average of 0.57, well within one standard deviation of normal.

The activist angle, flagged in previous notes, remains worth monitoring. REH Advisors holds a Schedule 13D position, confirmed activist in intent, at 5.1% of shares, trimmed from 6.3% in August when the firm sold 2.375 million shares at $89.41 apiece. That stake now sits just above the 5% threshold at which a further reduction could drop off the 13D register entirely without a new filing. Per standard 13D/G disclosure rules, stakes are as last reported around that threshold, and a holder dropping below 5% may not file again. With the stock now at $114.21, up substantially from the August disposal price, the question of what REH does next is live. CEO Franklin Myers, separately, bought 15,000 shares at $85.30 in August, an open-market purchase worth $1.28 million with no 10b5-1 plan attached.

ORTEX also flags a pending spinoff of the Lubricants and Specialties segment as a candidate event for the S&P MidCap 400, Russell 1000, and Russell 3000, putting the probability of a share-count decrease in each index at 60%. These are ORTEX forecasts, not confirmed announcements. The estimated announcement date is December 2026, with an effective date of December 31, 2027. Dates are estimated. The spinoff structure, if it proceeds, would be the central mechanical event for index-tracker positioning into year-end 2027.

What matters most now is the Q3 results themselves and whether management commentary on refinery throughput and the lubricants segment addresses the operational concerns that have kept several analysts at neutral ratings despite their higher targets.